Results 11 to 20 of about 66,641 (188)

Doxophylline With Paroxysmal Supraventricular Tachycardia: A Case Report

open access: yesClinical Medicine Insights: Case Reports
Purpose: We report a case of a patient experiencing paroxysmal supraventricular tachycardia after infusing doxophylline. Methods: Clinical evaluations and the electrocardiogram were performed by specialists.
Dandan Yu, Min Liu, Wei Tang
doaj   +2 more sources

Cisplatin induced paroxysmal supraventricular tachycardia

open access: yesIndian Journal of Medical and Paediatric Oncology, 2013
Cisplatin or cis-diamminedichloroplatinum (CDDP) is the first member of a class of platinum-containing anti-cancer drugs that act by binding to and causing cross-linking of deoxyribonucleic acid, which ultimately triggers apoptosis. Cisplatin has a broad-
Waseem Raja   +4 more
doaj   +2 more sources

Clinical Practice Guidelines for paroxysmal supraventricular tachycardia. [PDF]

open access: yesMedisur, 2009
Clinical Practice Guidelines for paroxysmal supraventricular tachycardia. These are arrhythmias in which structures placed above the bifurcation of the bundle of His are involved; characterized by tachycardia with abrupt starting and ending.
Brandy Viera Valdés   +3 more
doaj   +3 more sources

Paroxysmal supraventricular tachycardia: physiopathology and management

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2014
Paroxysmal supraventricular tachycardia (PSVT) is the most frequent arrhythmia in newborns and infants. Most supraventricular tachycardias affect structurally healthy hearts. Apart from occasional detection by parents, most tachycardias in this age group
Paola Neroni   +6 more
doaj   +2 more sources

An Ayurvedic Management of Paroxysmal Supraventricular Tachycardia [PDF]

open access: yes, 2022
Background: Paroxysmal Supraventricular Tachycardia is a type of Supraventricular tachycardia (SVT) and is defined as intermittent SVT and typically presents with a ventricular rhythm of 160 bpm.
Kumbhar, Prakash   +2 more
core   +1 more source

A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology [PDF]

open access: yes, 2009
Aims ATI-2042 (budiodarone) is a chemical analogue of amiodarone with a half life of 7 h. It is electrophysiologically similar to amiodarone, but may not have metabolic and interaction side effects.
Camm, AJ   +5 more
core   +1 more source

Carbamazepine-responsive paroxysmal nausea and vomiting in a patient with meningeal carcinomatosis [PDF]

open access: yes, 2006
In neurology, paroxysmal syndromes are well-known, eg, as manifestations of multiple sclerosis. We report a patient with meningeal carcinomatosis, who presented with therapyrefractory nausea and vomiting.
Borasio, Gian Domenico
core   +1 more source

Chronic Paroxysmal Hemicrania: The First Possible Bilateral Case [PDF]

open access: yes, 1986
There are three headaches syndromes that are typically characterized by strictly unilateral and always same-sided attacks: cluster headache, “cervicogenic” headache, and chronic paroxysmal hemicrania (CPH).
Pfaffenrath, Volker, Pöllmann, Walter
core   +1 more source

DISORDERS OF CARDIAC RHYTHM IN PATIENTS WITH PRE-EXCITATION SYNDROME OF VENTRICLES AND THEIR PHARMACOLOGICAL CORRECTION

open access: yesПроблеми екології та медицини, 2020
The aim of the research was to analyze the possibility of using different antiarrhythmic agents in patients with pre-excitation syndrome and disorders of cardiac rhythm.
R.V. Lutsenko   +2 more
doaj   +1 more source

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES) [PDF]

open access: yesActa Medica Iranica, 1986
Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY    +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy